Shneider AM - Search Results

1

Development of a vaccine against pandemic influenza viruses: current status and perspectives.

Ilyinskii PO, Thoidis G, Shneider AM. Ilyinskii PO, et al. Among authors: shneider am. Int Rev Immunol. 2008;27(6):392-426. doi: 10.1080/08830180802295765. Int Rev Immunol. 2008. PMID: 19065349 Review.

2

Inhibition of influenza M2-induced cell death alleviates its negative contribution to vaccination efficiency.

Ilyinskii PO, Gambaryan AS, Meriin AB, Gabai V, Kartashov A, Thoidis G, Shneider AM. Ilyinskii PO, et al. Among authors: shneider am. PLoS One. 2008 Jan 16;3(1):e1417. doi: 10.1371/journal.pone.0001417. PLoS One. 2008. PMID: 18197240 Free PMC article.

3

Toxicity of influenza A virus matrix protein 2 for mammalian cells is associated with its intrinsic proton-channeling activity.

Ilyinskii PO, Gabai VL, Sunyaev SR, Thoidis G, Shneider AM. Ilyinskii PO, et al. Among authors: shneider am. Cell Cycle. 2007 Aug 15;6(16):2043-7. doi: 10.4161/cc.6.16.4564. Epub 2007 Jun 12. Cell Cycle. 2007. PMID: 17700063

4

The proteosomal degradation of fusion proteins cannot be predicted from the proteosome susceptibility of their individual components.

Ilyinskii PO, Meriin AB, Gabai VL, Usachev EV, Prilipov AG, Thoidis G, Shneider AM. Ilyinskii PO, et al. Among authors: shneider am. Protein Sci. 2008 Jun;17(6):1077-85. doi: 10.1110/ps.083443908. Epub 2008 Apr 14. Protein Sci. 2008. PMID: 18411420 Free PMC article.

5

Protection against mouse and avian influenza A strains via vaccination with a combination of conserved proteins NP, M1 and NS1.

Zhirnov OP, Isaeva EI, Konakova TE, Thoidis G, Piskareva LM, Akopova II, Kartashov A, Altstein AD, Ilyinskii PO, Shneider AM. Zhirnov OP, et al. Among authors: shneider am. Influenza Other Respir Viruses. 2007 Mar;1(2):71-9. doi: 10.1111/j.1750-2659.2007.00010.x. Influenza Other Respir Viruses. 2007. PMID: 18784792 Free PMC article.

6

Effective expression of recombinant cytotoxic protein via its attachment to a polyglutamine domain.

Ilyinskii PO, Nurminskaya MV, Gabai VL, Prilipov AG, Usachev EV, Zakharova LG, Thoidis G, Altstein AD, Shneider AM. Ilyinskii PO, et al. Among authors: shneider am. OMICS. 2009 Jun;13(3):211-7. doi: 10.1089/omi.2009.0006. OMICS. 2009. PMID: 19441878

7

Importance of mRNA secondary structural elements for the expression of influenza virus genes.

Ilyinskii PO, Schmidt T, Lukashev D, Meriin AB, Thoidis G, Frishman D, Shneider AM. Ilyinskii PO, et al. Among authors: shneider am. OMICS. 2009 Oct;13(5):421-30. doi: 10.1089/omi.2009.0036. OMICS. 2009. PMID: 19594376

8

Prime-boost vaccination with a combination of proteosome-degradable and wild-type forms of two influenza proteins leads to augmented CTL response.

Ilyinskii PO, Meriin AB, Gabai VL, Zhirnov OP, Thoidis G, Shneider AM. Ilyinskii PO, et al. Among authors: shneider am. Vaccine. 2008 Apr 24;26(18):2177-85. doi: 10.1016/j.vaccine.2008.02.050. Epub 2008 Mar 14. Vaccine. 2008. PMID: 18400345 Free PMC article.

9

Adjuvant potential of aggregate-forming polyglutamine domains.

Ilyinskii PO, Thoidis G, Sherman MY, Shneider A. Ilyinskii PO, et al. Vaccine. 2008 Jun 19;26(26):3223-6. doi: 10.1016/j.vaccine.2008.03.078. Epub 2008 Apr 18. Vaccine. 2008. PMID: 18467011

10

Immunization with influenza A NP-expressing vaccinia virus recombinant protects mice against experimental infection with human and avian influenza viruses.

Altstein AD, Gitelman AK, Smirnov YA, Piskareva LM, Zakharova LG, Pashvykina GV, Shmarov MM, Zhirnov OP, Varich NP, Ilyinskii PO, Shneider AM. Altstein AD, et al. Among authors: shneider am. Arch Virol. 2006 May;151(5):921-31. doi: 10.1007/s00705-005-0676-9. Epub 2005 Nov 15. Arch Virol. 2006. PMID: 16292596

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

33 results

Search Page